IRCT201111042935N6已完成2 期
Effect of Vitamin B6 versus propranolol in patients with neuroleptic -induced Akathisia : ?A randomized-double blind study
Vice chancellor for research, Kurdistan University of Medical Sciences0 个研究点目标入组 51 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •being hospitalized ;receiving neuroleptic
- •medication; Presence of akathisia based on DSM-IV criteria; Baseline
- •Barnes Akathisia Scale (BAS) score of at least 2
- •Exclusion criteria: any hepatic or renal
- •disease; change in the dose of anticholinergic drugs within 5 days
- •before the trial; receiving any beta-blocker medication during the study
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Comparison of the effect of vitamin B6 and propranolol on Prevention of relapse of migraine headaches in children aged 7-17 years old referring to the pediatric clinic of Amirkabir Arak Hospitalmigrain.MigraineIRCT20191104045328N2Arak University of Medical Sciences62
进行中（未招募）
不适用
PROPRANOLOL IN BURNT ADULT PATIENTSBURNT-INDUCED SINUSAL TACHYCARDIAEUCTR2014-001380-13-ESAbelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran
进行中（未招募）
1 期
Prednisolone and vitamin B1, B6, and B12 in patients with Post-COVID-19-Syndrome (PC19S) – a randomized controlled trial in primary carePost-COVID-19-Syndrome (PC19S)EUCTR2022-001041-20-DEniversity Hospital Wuerzburg340
招募中
2 期
Prednisolone and vitamin B1, B6, and B12 in patients with Post-COVID-19-Syndrome (PC19S) – a randomized controlled trial in primary carePost-COVID 19 condition, unspecifiedU09.9Post COVID-19 condition, unspecifiedDRKS00029617niversitätsklinikum Würzburg, Institut für Allgemeinmedizin300
招募中
2 期
Evaluation of the effect of vitamin B6 on blood cells count in patients using linezolidIRCT20150721023282N13Esfahan University of Medical Sciences70